These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29049013)

  • 21. Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma.
    Zhou W; Yue H; Li C; Chen H; Yuan Y
    Tumour Biol; 2016 Feb; 37(2):2613-9. PubMed ID: 26392112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Wang Y; Liang L; Zhang J; Li M; Zhu J; Gong C; Yang L; Zhu J; Chen L; Ni R
    Tumour Biol; 2015 Nov; 36(11):8735-45. PubMed ID: 26050229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
    Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers.
    Kashyap MK; Marimuthu A; Kishore CJ; Peri S; Keerthikumar S; Prasad TS; Mahmood R; Rao S; Ranganathan P; Sanjeeviah RC; Vijayakumar M; Kumar KV; Montgomery EA; Kumar RV; Pandey A
    Cancer Biol Ther; 2009 Jan; 8(1):36-46. PubMed ID: 18981721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulated miR-26a promotes proliferation, migration, and invasion
    Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
    FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of long non-coding RNA MIR31HG and its role in esophageal squamous cell carcinoma.
    Sun K; Zhao X; Wan J; Yang L; Chu J; Dong S; Yin H; Ming L; He F
    Life Sci; 2018 Jun; 202():124-130. PubMed ID: 29605445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of microRNA-98 increases radiosensitivity in esophageal squamous cell carcinoma.
    Jin YY; Chen QJ; Wei Y; Wang YL; Wang ZW; Xu K; He Y; Ma HB
    J Radiat Res; 2016 Sep; 57(5):468-476. PubMed ID: 27422937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
    Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
    Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
    Mao Y; Liu J; Zhang D; Li B
    Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
    Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
    Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.